Literature DB >> 16390942

Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Claudio Piersimoni1, Armando Olivieri, Luca Benacchio, Claudio Scarparo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16390942      PMCID： PMC1351976          DOI： 10.1128/JCM.44.1.20-28.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  32 in total

1.  Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates.

Authors:  H J Marttila; M Marjamäki; M K Viljanen; H Soini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

2.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

3.  The resurgence of tuberculosis: is your laboratory ready?

Authors:  F C Tenover; J T Crawford; R E Huebner; L J Geiter; C R Horsburgh; R C Good
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

4.  Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method.

Authors:  B Littenberg; L E Moses
Journal:  Med Decis Making       Date:  1993 Oct-Dec       Impact factor: 2.583

5.  Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

Authors:  L E Moses; D Shapiro; B Littenberg
Journal:  Stat Med       Date:  1993-07-30       Impact factor: 2.373

6.  Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

Authors:  M M Park; A L Davis; N W Schluger; H Cohen; W N Rom
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

7.  Guidelines for meta-analyses evaluating diagnostic tests.

Authors:  L Irwig; A N Tosteson; C Gatsonis; J Lau; G Colditz; T C Chalmers; F Mosteller
Journal:  Ann Intern Med       Date:  1994-04-15       Impact factor: 25.391

8.  Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.

Authors:  J S Bergmann; G L Woods
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

9.  Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pascale Bemer; Thomas Bodmer; Juerg Munzinger; Monique Perrin; Véronique Vincent; Henri Drugeon
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.

Authors:  Isik Somuncu Johansen; Vibeke Østergaard Thomsen; Merja Marjamäki; Anaida Sosnovskaja; Bettina Lundgren
Journal:  Diagn Microbiol Infect Dis       Date:  2004-10       Impact factor: 2.803
View more
  38 in total

1.  Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  M Espasa; M Salvadó; E Vicente; G Tudó; F Alcaide; P Coll; N Martin-Casabona; M Torra; D Fontanals; J González-Martín
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

Authors:  Olga Ignatyeva; Irina Kontsevaya; Alexander Kovalyov; Yanina Balabanova; Vladislav Nikolayevskyy; Kadri Toit; Anda Dragan; Daniela Maxim; Svetlana Mironova; Tiina Kummik; Ionela Muntean; Ekaterina Koshkarova; Francis Drobniewski
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

3.  Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis.

Authors:  Meenu Sharma; Louise Thibert; Pamela Chedore; Cary Shandro; Frances Jamieson; Gregory Tyrrell; Sara Christianson; Hafid Soualhine; Joyce Wolfe
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

4.  Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Authors:  Silke Feuerriegel; Helen S Cox; Nana Zarkua; Hamraev A Karimovich; Kai Braker; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

5.  Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.

Authors:  I Kontsevaya; S Mironova; V Nikolayevskyy; Y Balabanova; S Mitchell; F Drobniewski
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

6.  Modification of proportion sensitivity testing method for ethionamide.

Authors:  Rajagopalan Lakshmi; Ranjani Ramachandran; K Devika; G Radhika; A Syam Sundar; Fathima Rahman; N Selvakumar; Vanaja Kumar
Journal:  World J Microbiol Biotechnol       Date:  2013-01-12       Impact factor: 3.312

7.  PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.

Authors:  Silke Feuerriegel; Viola Schleusener; Patrick Beckert; Thomas A Kohl; Paolo Miotto; Daniela M Cirillo; Andrea M Cabibbe; Stefan Niemann; Kurt Fellenberg
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

8.  Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.

Authors:  Akos Somoskovi; Jillian Dormandy; Dimitra Mitsani; Jeremy Rivenburg; Max Salfinger
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

9.  Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.

Authors:  Paolo Miotto; Nuccia Saleri; Mathurin Dembelé; Martial Ouedraogo; Gisèle Badoum; Gabriele Pinsi; Giovanni B Migliori; Alberto Matteelli; Daniela M Cirillo
Journal:  BMC Infect Dis       Date:  2009-08-28       Impact factor: 3.090

10.  Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.